Sarver Molecular Cardiovascular Research Program, University of Arizona, Tucson, AZ 85724, USA.
J Mol Cell Cardiol. 2013 Jan;54:90-7. doi: 10.1016/j.yjmcc.2012.11.012. Epub 2012 Dec 5.
Titin-based passive stiffness is post-translationally regulated by several kinases that phosphorylate specific spring elements located within titin's elastic I-band region. Whether titin is phosphorylated by calcium/calmodulin dependent protein kinase II (CaMKII), an important regulator of cardiac function and disease, has not been addressed. The aim of this work was to determine whether CaMKIIδ, the predominant CaMKII isoform in the heart, phosphorylates titin, and to use phosphorylation assays and mass spectrometry to study which of titin's spring elements might be targeted by CaMKIIδ. It was found that CaMKIIδ phosphorylates titin in mouse LV skinned fibers, that the CaMKIIδ sites can be dephosphorylated by protein phosphatase 1 (PP1), and that under baseline conditions, in both intact isolated hearts and skinned myocardium, about half of the CaMKIIδ sites are phosphorylated. Mass spectrometry revealed that both the N2B and PEVK segments are targeted by CaMKIIδ at several conserved serine residues. Whether phosphorylation of titin by CaMKIIδ occurs in vivo, was tested in several conditions using back phosphorylation assays and phospho-specific antibodies to CaMKIIδ sites. Reperfusion following global ischemia increased the phosphorylation level of CaMKIIδ sites on titin and this effect was abolished by the CaMKII inhibitor KN-93. No changes in the phosphorylation level of the PEVK element were found suggesting that the increased phosphorylation level of titin in IR (ischemia reperfusion) might be due to phosphorylation of the N2B element. The findings of these studies show for the first time that titin can be phosphoryalated by CaMKIIδ, both in vitro and in vivo, and that titin's molecular spring region that determines diastolic stiffness is a target of CaMKIIδ.
肌联蛋白的被动刚度是通过几种激酶进行翻译后调节的,这些激酶磷酸化位于肌联蛋白弹性 I 带区域内的特定弹簧元件。钙/钙调蛋白依赖性蛋白激酶 II(CaMKII)是否磷酸化肌联蛋白,CaMKII 是心脏功能和疾病的重要调节因子,尚未得到解决。这项工作的目的是确定心脏中主要的 CaMKII 同工型 CaMKIIδ 是否磷酸化肌联蛋白,并使用磷酸化测定和质谱法研究 CaMKIIδ 可能靶向肌联蛋白的哪些弹簧元件。结果发现 CaMKIIδ 在小鼠 LV 去皮纤维中磷酸化肌联蛋白,CaMKIIδ 位点可被蛋白磷酸酶 1(PP1)去磷酸化,并且在基础条件下,在完整分离的心脏和去皮心肌中,约一半的 CaMKIIδ 位点被磷酸化。质谱分析表明,N2B 和 PEVK 片段都在几个保守丝氨酸残基上被 CaMKIIδ 靶向。使用反向磷酸化测定和针对 CaMKIIδ 位点的磷酸化特异性抗体,在几种条件下测试了 CaMKIIδ 对肌联蛋白的磷酸化是否发生在体内。在全球缺血后再灌注时,CaMKIIδ 对肌联蛋白上 CaMKIIδ 位点的磷酸化水平增加,而这种作用被 CaMKII 抑制剂 KN-93 所消除。在 PEVK 元件的磷酸化水平没有发现变化,这表明 IR(缺血再灌注)中肌联蛋白的磷酸化水平增加可能是由于 N2B 元件的磷酸化。这些研究的结果首次表明,肌联蛋白可以在体外和体内被 CaMKIIδ 磷酸化,并且决定舒张刚度的肌联蛋白的分子弹簧区域是 CaMKIIδ 的靶标。